Insider Analysis From Finnegan Henderson: India's Indecision - How To Provide Pharma Companies With Clinical Trial Data Exclusivity
This article was originally published in PharmAsia News
Executive Summary
By: Nathan A. Evans and Seth I. Heller, Finnegan, Henderson, Washington, D.C